News Overview

The Company has duly accepted the LoI on March 28, 2022

The Board of Directors in its meeting held on March 29, 2022 has approved raising of capital for an amount up to Rs12,000 crore.

Let us very quickly look at what it really means.

The decision has put to rest the speculations regarding the import policy regime for Tur and Urad in the coming financial year (2022-23) and it also signals a stable policy regime which will benefit all the stakeholders.

Project for setting up of Assembly, Testing, Marking and Packaging (ATMP) of NAND Flash memory under PLI Scheme.

Here is the important stock market news to watch out for today.

Asian markets opened in the red led by the Japanese 'Nikkei' which succumbed to profit-booking after the stellar rally over the last fortnight.

Check out the stocks that will be in focus during trade today based on recent and latest news developments.

Ambika Cotton Mills announced the resignation of KN Sreedharan DIN 00321585 Independent Director of the Company with effect from 24 March 2022

Lupin today announced that it has received approval from the United States Food and Drug Administration FDA for its Abbreviated New Drug Application ANDA Sildenafil for Oral Suspension 10 mgmL to market a generic equivalent of Revatio for Oral Suspension 10 mgmL of Viatris Specialty LLC The product will be manufactured at Lupins facility in Goa India Sildenafil for Oral Suspension 10 mgmL RLD Revatio […]